集团首页| 紫杉科技| 红豆杉药业| 红豆杉医院| 红豆杉庄| 上海开润| 尚志药业| 培育基地| 贵宾留言|  
 

主 要 产 品

典 型 病 例
集 团 荣 誉
联 系 我 们
在 线 求 医
   


           达克素片和达克素胶囊

  黑龙江省红豆杉医药研究所附属门诊研制的两种抗癌药品,达克素片剂及达克素胶囊获省药品监督管理局生产批复.

  由黑龙江省红豆杉医药研究院肿瘤防治专家组研发的抗癌新药达克素片及达克素胶囊目前已通过黑龙江药品监督管理局的审批,(见黑龙江省药品监督管理局文件.黑药管注发[2002]99号).准许生产并投放市场,批准文号分别为黑药制字(2002)Z第0003号,黑药制字(2002)Z第0004号.

  抗癌新药达克素片及达克素胶囊的面市,无疑给众多的癌症患者带去了福音,该药属广谱抗癌药,主要用于肺癌,卵巢癌,乳腺癌,头颈鳞状细胞癌,肝癌,胰腺癌,胃癌,胸腺癌,黑色素瘤,食道癌,淋巴癌,多发性骨髓瘤及人体其他部分的实体瘤和白血病的治疗,具有阵痛和提高肌体免疫力的作用

 

Anticancer preparation-Dakesu

  Dakesu is manufactured by a scientific process from the primary raw material of northeast HongDouShan and The basis have taxol and other forties kinds of anticancer activity terpene compound.
  Taxol is a new type of anticanaliculus medication, accelerates to polymerize canaliculus and stabilizes canaliculus, The stabilization function controls canaliculus net to reorganize dynamically, and restrains cell division.

  Indications: Extensive gammarayspectrum anticancer and antileukaemia medicine. Treating cancer of the ovary, the lung, the galactophore,the pancreas,the uterus,the thymus gland,the prostate,the intestines,the stomach, the urinary bladder,the head and neck squama state cell,the esophagus, the lymph, the medulla, the liver,and tumour of the melanin,other entity,leukaemia and so on.

  Caution: part sufferers (2%) from a long-term use having the reaction of reversibility digestive tract and hypersusceptibility, but the phenomenon disappearing namely after stopping remedy.

Directions for use:

Taking orally 4 to 7 pieces each time, 3 to 4 times daily (10 to 15 minutes after meal)

Standard: 0.35g × 60 pieces

 
 
 

hongdoushan@126.com

 

 

    | 返回首页 | 加入收藏 |